UroMems is an innovative medtech company.
UroMems has raised $60.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2026.
UroMems's investors include Bpifrance, BNP Paribas, Ajax Health, European Innovation Council, Crédit Agricole.
UroMems is headquartered in Grenoble, France.
UroMems is an innovative medtech company.
UroMems is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"UroMems — Funding & Investors." VCBacked, May 13, 2026, https://www.vcbacked.co/company/uromems. Accessed September 29, 2026.
VCBacked. (2026). UroMems — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/uromems
{{cite web |title=UroMems — Funding & Investors |url=https://www.vcbacked.co/company/uromems |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated